Latest Edwards Lifesciences News & Updates
See the latest news and media coverage for Edwards. We track all announcements, press releases, and industry mentions in real time, all in one place.
Structural heart medical device manufacturer
edwards.com- Headquarters
- Irvine, United States
- Founded year
- 1958
- Company type
- Public company
- Number of employees
- 10,000+
Last updated
Latest news about Edwards Lifesciences (Edwards)
In short: Edwards reported strong Q1 2026 growth, secured FDA approval for its Sapien M3 system, and scrapped its $945 million acquisition of JenaValve.
Company announcements
-
Edwards Lifesciences announces CFO appointment
Theodora Mistras succeeds Scott Ullem effective end of May 2026. She joins from Viatris.
-
Edwards announces 10-year COMMENCE trial results
Results show 97.9% freedom from structural valve deterioration for RESILIA tissue in aortic valves. Data presented at AATS meeting.
-
Edwards announces Q1 2026 financial results
The earnings release includes Forward-Looking Statements and Non-GAAP Reconciliations.
-
Edwards Lifesciences reports Q1 2026 results
Sales grew 16.7% to $1.65B; raises FY 2026 guidance to 9-11% sales growth and $2.95-$3.05 adjusted EPS.
Media coverage
-
Edwards Lifesciences (EW) is Benefitting from Expanding Its Aortic Valve Franchise
Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for the "Artisan Mid Cap Fund". A copy of the letter is available...
-
Edwards Lifesciences Shareholders Approve Expanded Equity Incentive Plan
Detailed price information for Edwards Lifesciences Corp (EW-N) from The Globe and Mail including charting and trades.
-
Edwards Lifesciences (NYSE: EW) lifts Q1 2026 sales on TAVR and TMTT growth
Unless otherwise indicated or otherwise required by the context, the terms “we,” “our,” “it,” “its,” “Company,” “Edwards,” and “Edwards Lifesciences” refer to Edwards Lifesciences Corporation...
-
Resilia tissue developed by Edwards Lifesciences associated with long-term durability
However, few surgical valve trials have tracked patients out a decade or more, so this trial helps better inform decision making. Edwards Lifesciences said the...
Track Edwards and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Edwards competitors & trending companies
Browse news for competitors to Edwards and other trending companies.
Abbott
Medtronic
Boston Scientific
O-I
TMC
Agora
Applied Digital
QS
Silex
iQIYI
Kopin
Joby
Visteon
Ready Capital
Archer
Aptar
Lotus
Redwire
SmartStop
Waystar
Bristow Group
MaxLinear
Energy Fuels
Mobileye
Dakota Gold
Ubiquiti
Hudbay Minerals
Novavax
Forestar Group
Everspin
Trump Media & Technology Group
Tilde Research
Innodata
Castellum.AI
Xerox
Webull